Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

The companies entered into an agreement to allow Nippon to evaluate Phosphagenics' topical TPM/diclofenac to treat pain. If successful, the companies intend to enter into a deal granting the pharma rights to the transdermal gel formulation of diclofenac, an NSAID delivered using the TPM delivery system. Terms were not disclosed. ...